What are the differential diagnoses and management for a patient with a one‑week history of epigastric/right upper quadrant pain?

Differential Diagnoses and Management for One-Week Epigastric/Right Upper Quadrant Pain

Begin with abdominal ultrasound immediately as the mandatory first-line imaging study, followed by comprehensive liver function tests, to differentiate between biliary pathology (cholecystitis, choledocholithiasis), hepatic disease, and gastrointestinal causes. 1

Initial Diagnostic Approach

Immediate Laboratory Evaluation

• Obtain comprehensive liver function tests including AST, ALT, alkaline phosphatase, total/direct bilirubin, and GGT to assess for cholestatic versus hepatocellular patterns 1
• Complete blood count to detect leukocytosis suggesting infection or inflammation 2
• C-reactive protein and inflammatory markers to gauge severity of inflammation 2
• Serum lipase or amylase (>3× upper limit of normal confirms pancreatitis if present) 1
• Pregnancy test in women of reproductive age to exclude ectopic pregnancy 3

First-Line Imaging: Abdominal Ultrasound

Ultrasound is the initial evaluation mandated by the American College of Radiology for right upper quadrant pain, achieving 71-97% specificity for confirming or excluding biliary obstruction 1. This modality provides:

• Detection of gallstones with 96% accuracy and assessment of gallbladder wall thickening (>3mm), pericholecystic fluid, and Murphy's sign 4, 1
• Evaluation of common bile duct dilatation (normal CBD <6mm; dilated suggests obstruction), with 95-96% negative predictive value for choledocholithiasis when normal 1
• Assessment for cirrhosis or hepatic parenchymal disease with 65-95% sensitivity 4, 1
• Identification of hepatic masses or abscesses that may cause localized pain 2

Key Differential Diagnoses Based on One-Week Duration

Biliary Pathology (Most Common for RUQ Pain)

Acute Cholecystitis

• Clinical presentation: Right upper quadrant pain, Murphy's sign (inspiratory arrest with palpation), fever, and leukocytosis 4
• Ultrasound findings: Gallbladder wall thickening >3mm, pericholecystic fluid, gallstones impacted in cystic duct, positive sonographic Murphy's sign 4
• Management: Early laparoscopic cholecystectomy within 7-10 days of symptom onset is superior to delayed treatment 4. For immunocompetent patients with adequate source control, use amoxicillin/clavulanate 2g/0.2g q8h 4. For critically ill or immunocompromised patients, use piperacillin/tazobactam 6g/0.75g loading dose then 4g/0.5g q6h 4

Choledocholithiasis (Common Bile Duct Stones)

• Clinical presentation: Intermittent RUQ pain, jaundice, elevated alkaline phosphatase and bilirubin (cholestatic pattern) 4, 1
• Diagnostic algorithm: If ultrasound shows dilated CBD or elevated liver function tests suggest obstruction, proceed directly to MRCP (sensitivity 85-100%, specificity 90%) rather than CT 1
• Management: Therapeutic ERCP with sphincterotomy and stone extraction when confirmed 1

Acute Cholangitis

• Clinical presentation: Charcot's triad of RUQ pain, fever with rigors, and jaundice 4, 1
• Management: Initiate IV antibiotics immediately (piperacillin/tazobactam for critically ill) and obtain urgent ERCP within 24 hours for biliary decompression 4, 1

Hepatic Causes

Hepatitis (Viral, Alcoholic, or Drug-Induced)

• Clinical presentation: RUQ tenderness, elevated transaminases (AST/ALT >10× normal suggests hepatocellular injury), possible jaundice 4, 2
• Diagnostic clues: Hepatocellular pattern (transaminases >> alkaline phosphatase), history of alcohol use, new medications within 6 weeks, or risk factors for viral hepatitis 4

Hepatic Abscess

• Clinical presentation: Fever (67-98% of cases), localized RUQ pain with positive hepatic punch sign, leukocytosis 2
• Imaging: CT with IV contrast has >95% sensitivity for detecting abscesses 2
• Management: Metronidazole 500mg PO three times daily for 7-10 days if amoebic; percutaneous drainage plus antibiotics if pyogenic 2

Gastrointestinal Causes

Peptic Ulcer Disease or Gastritis

• Clinical presentation: Epigastric pain that may radiate to RUQ, relationship to meals, possible relief with antacids 4
• Management approach: In patients <55 years without alarm features (weight loss, dysphagia, bleeding), initiate H. pylori test-and-treat strategy using urea breath test or stool antigen test, followed by PPI therapy (omeprazole 20-40mg daily for 4-8 weeks) if symptoms persist 4, 1

Perforated Peptic Ulcer

• Clinical presentation: Sudden-onset severe epigastric pain becoming generalized, abdominal rigidity, absent bowel sounds 4
• Imaging: CT shows extraluminal gas and intra-abdominal fluid 4
• Management: Surgical repair with laparoscopic/open suture repair; antibiotics for 4 days post-operatively if source control adequate 4

Biliary Pancreatitis

• Clinical presentation: Epigastric pain radiating to back, nausea/vomiting, elevated lipase >3× normal 1
• Management: If gallstones confirmed, perform early ERCP within 72 hours if CBD stone visible or CBD persistently dilated; schedule laparoscopic cholecystectomy during same admission to prevent recurrence 1

Extra-Abdominal Causes to Consider

Lower Lobe Pneumonia or Pleurisy

• Clinical presentation: Right lower chest pain with positive hepatic punch, cough, fever 2, 3
• Evaluation: Chest X-ray to exclude pulmonary pathology 3

Abdominal Wall Pain (Musculoskeletal)

• Clinical presentation: Pain worsened by movement or palpation, reproducible tenderness 3
• Diagnostic test: Carnett's sign (increased pain with abdominal wall tensing) suggests musculoskeletal origin 3

Advanced Imaging Algorithm When Ultrasound Is Negative or Equivocal

When to Order MRCP

MRCP is the preferred next imaging study when:

• Ultrasound shows dilated CBD but no visible stone, or elevated cholestatic liver enzymes persist despite normal ultrasound 1
• Suspected choledocholithiasis (MRCP achieves 85-100% sensitivity, 90% specificity) 1
• Recurrent RUQ pain with negative initial workup, as MRCP provides superior visualization of the entire biliary tree compared to repeat ultrasound or CT 1

Order "MRI abdomen with MRCP" which includes heavily T2-weighted sequences that make bile appear bright and stones appear as dark filling defects 1. IV gadolinium contrast is optional for detecting stones themselves but helpful for evaluating complications (cholangitis, hepatic masses, alternative diagnoses) 1.

When to Order CT Abdomen/Pelvis with IV Contrast

Reserve CT for critically ill patients with:

• Peritoneal signs suggesting perforation, abscess, or complicated cholecystitis (emphysematous cholecystitis, gallbladder perforation) 4, 1
• Suspected mesenteric ischemia requiring CT angiography 4
• Atypical presentation or multiple potential diagnoses where comprehensive abdominal survey is needed 3, 5

CT has significant limitations: Lower sensitivity than ultrasound for gallstones (39-75% vs 96%), and up to 80% of gallstones are non-calcified and invisible on CT 1.

Management Based on Specific Diagnoses

Uncomplicated Cholecystitis

• Early laparoscopic cholecystectomy within 7-10 days is superior to delayed treatment 4
• One-shot antibiotic prophylaxis if early intervention; no post-operative antibiotics needed 4
• If delayed treatment chosen (not recommended in immunocompromised): antibiotics for no more than 7 days, then planned delayed cholecystectomy 4

Complicated Cholecystitis

• Laparoscopic cholecystectomy with open as alternative 4
• Antibiotic therapy for 4 days in immunocompetent patients if source control adequate 4
• Antibiotic therapy up to 7 days in immunocompromised or critically ill patients based on clinical response 4
• Cholecystostomy may be option for patients unfit for surgery who don't improve after antibiotic therapy, though inferior to cholecystectomy in critically ill 4

Choledocholithiasis with Obstruction

• Urgent ERCP within 24 hours if cholangitis present (fever, jaundice, RUQ pain) 1
• Early ERCP within 72 hours if CBD stone visible on imaging or persistently dilated CBD 1
• Laparoscopic cholecystectomy during same admission after ERCP to prevent recurrence 1

Empiric Medical Management When Imaging Negative

If ultrasound, HIDA scan, and CT are all negative but pain persists:

• Initiate empiric PPI trial (omeprazole 20-40mg daily for 4-8 weeks) to address possible GERD, peptic ulcer disease, or gastroduodenal sources 4, 1
• If PPI trial fails, proceed to upper endoscopy to directly evaluate for erosive esophagitis or ulcer disease 1
• Do not repeat ultrasound or CT after initial negative workup; these are inferior to MRCP for subtle biliary abnormalities 1

Critical Pitfalls to Avoid

• Do not rely on ultrasound alone for distal CBD evaluation: Overlying bowel gas limits visualization, with sensitivity only 22.5-75% for CBD stones 1
• Do not order CT as first-line imaging for RUQ pain: CT has lower sensitivity for gallstones and biliary pathology compared to ultrasound, and exposes patient to unnecessary radiation 1, 3
• Do not perform ERCP as diagnostic test: ERCP carries 3-5% risk of pancreatitis, 2% bleeding risk, 1% cholangitis risk, and 0.4% mortality; reserve for therapeutic intervention after non-invasive imaging confirms need 4, 1
• Do not dismiss heterogeneous liver on ultrasound as "normal variant": This finding warrants investigation with liver function tests and consideration of MRI for comprehensive evaluation, especially with persistent pain 1
• Do not delay imaging in patients on corticosteroids: Prednisone suppresses fever and inflammatory markers, masking typical signs of cholecystitis or cholangitis; maintain low threshold for advanced imaging 1
• Do not ignore alarm features: Weight loss, dysphagia, bleeding, or age >55 years mandate endoscopy rather than empiric treatment 4

Special Population Considerations

Women of Reproductive Age

• Always obtain pregnancy test to exclude ectopic pregnancy before imaging 3
• Consider gynecologic causes: Pelvic inflammatory disease, adnexal torsion, ovarian cyst rupture 3

Elderly Patients

• May present with atypical symptoms and blunted inflammatory response 6
• Higher threshold for advanced imaging due to increased risk of serious pathology 6

Immunocompromised or Critically Ill

• Broader antibiotic coverage required: Piperacillin/tazobactam or carbapenems rather than amoxicillin/clavulanate 4
• Longer antibiotic duration: Up to 7 days based on clinical response rather than standard 4 days 4
• Patients with ongoing infection beyond 7 days warrant diagnostic re-investigation for abscess or inadequate source control 4